Elevance Health (MEX:ELV) PE Ratio without NRI: 12.68 (As of Jul. 05, 2026) — 25% Below Median


MEX:ELV Elevance Health Inc MEX:ELV
71 GF Score
Price MXN7,144.06
GF Value MXN8,687.10
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Elevance Health PE Ratio without NRI?

Elevance Health MEX:ELV 71 PE Ratio without NRI is 12.68 as of Jul. 05, 2026, which is 25% below its 10-year median of 16.99. GuruFocus rates MEX:ELV with a GF Score™ of 71/100 and a GF Value™ of MXN8,687.10 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 16 Healthcare Plans companies, Elevance Health ranks better than 75% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-05), Elevance Health's share price is MXN7144.06. Elevance Health's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN563.88. Therefore, Elevance Health's PE Ratio without NRI for today is 12.68.

During the past 13 years, Elevance Health's highest PE Ratio without NRI was 23.84. The lowest was 8.32. And the median was 16.99.

Elevance Health's EPS without NRI for the three months ended in Mar. 2026 was MXN226.85. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was MXN563.88.

As of today (2026-07-05), Elevance Health's share price is MXN7144.06. Elevance Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN431.69. Therefore, Elevance Health's PE Ratio (TTM) for today is 16.54.

Warning Sign:

Elevance Health Inc stock PE Ratio (=17.77) is close to 2-year high of 19.53.

During the past years, Elevance Health's highest PE Ratio (TTM) was 23.13. The lowest was 10.39. And the median was 17.33.

Elevance Health's EPS (Diluted) for the three months ended in Mar. 2026 was MXN144.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN431.69.

Elevance Health's EPS (Basic) for the three months ended in Mar. 2026 was MXN144.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN432.75.


Elevance Health  (MEX:ELV) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Elevance Health PE Ratio without NRI Related Terms


Elevance Health PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Elevance Health's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health PE Ratio without NRI Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.84 17.65 14.23 11.17 11.57

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.68 11.78 10.53 11.57 9.51

MEX:ELV vs CI, HUM, CVS: PE Ratio without NRI Comparison

For the Healthcare Plans subindustry, Elevance Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health PE Ratio without NRI vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Elevance Health's PE Ratio without NRI falls into.


MEX:ELV
71GF Score
Elevance Health Inc MEX:ELV
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Elevance Health's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=7144.06/563.290
=12.68

Elevance Health's Share Price of today is MXN7144.06.
Elevance Health's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN563.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 12.68 mean?
Elevance Health (MEX:ELV) has a PE Ratio without NRI of 12.68 as of Jul. 05, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Elevance Health and its competitors. This is 25% below median its historical median of 16.99. Over the past decade, Elevance Health's PE Ratio without NRI has ranged from 8.32 to 23.84. According to the industry distribution chart, Elevance Health ranks #4 out of 16 companies in the Healthcare Plans industry, placing it in the top 25%.
Is Elevance Health's PE Ratio without NRI too high?
Elevance Health's current PE Ratio without NRI of 12.68 is 25% below median its 10-year median of 16.99. Over the past 10 years, this metric has ranged from a low of 8.32 to a high of 23.84. The Healthcare Plans industry median PE Ratio without NRI is 22.12. Elevance Health's value of 12.68 is 42.7% below this industry median. Based on the distribution chart, Elevance Health ranks #4 out of 16 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Elevance Health has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's PE Ratio without NRI compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #4 out of 16 companies for PE Ratio without NRI. This places Elevance Health in the top 25% of its industry — outperforming the majority of peers. The industry median PE Ratio without NRI is 22.12. Elevance Health's value of 12.68 is 42.7% below this benchmark. Historically, Elevance Health's own PE Ratio without NRI has ranged from 8.32 to 23.84 over the past decade. While the company's 10-year median is 16.99 vs. the industry median of 22.12, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Plans company?
The median PE Ratio without NRI among Healthcare Plans companies is 22.12, based on 16 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current PE Ratio without NRI of 12.68 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median PE Ratio without NRI is 22.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current PE Ratio without NRI is 12.68, which is 25% below median its own 10-year median of 16.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,687.10, compared to a current price of MXN7,144.06 — trading 17.8% below its estimated fair value. The current PE Ratio without NRI is 12.68, which is 25% below median its 10-year median of 16.99 and 42.7% below the Healthcare Plans industry median of 22.12. Elevance Health's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current PE Ratio without NRI is 12.68 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (MEX:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of MXN7,144.06 is trading 17.8% below its estimated GF Value™ of MXN8,687.10. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for MEX:ELV:

  • PE Ratio without NRI: 12.68 (25% below median its 10-year median of 16.99)
  • GF Value™: MXN8,687.10 vs. price of MXN7,144.06 (17.8% below fair value)
  • GF Score™: 71/100 with 8 warning signs
  • Industry Position: 42.7% below the Healthcare Plans median (#4 of 16)

No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
71GF Score

Get the complete analysis for MEX:ELV

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN7,144.06
Price
MXN8,687.10
GF Value